Emcure stake buy: Pharma firm to acquire 20.42% in Zuventus for Rs 724.9 crore; full ownership to aid consolidation
Emcure Pharmaceuticals will acquire the remaining 20.42% stake in Zuventus Healthcare for ₹724.9 crore, making it a wholly-owned subsidiary. The board has approved the acquisition from minority shareholders, with the transaction expected to close in the September quarter of FY26.
Emcure Pharmaceuticals will acquire the remaining 20.42% stake in Zuventus Healthcare for ₹724.9 crore, making it a wholly-owned subsidiary. The board has approved the acquisition from minority shareholders, with the transaction expected to close in the September quarter of FY26. What's Your Reaction?
